Profile data is unavailable for this security.
About the company
Abera Bioscience AB is a Sweden-based company, which is active in biotechnology. Abera Bioscience is platform and vaccine development company active in the medical, molecular and microbiological field. The Company’s purpose is to develop vaccine candidates based on its vaccine delivery platform to late pre-clinical or early clinical phase and to find licensing partners for further development of the vaccines. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and immunooncology. The business is located around the Nordic market.
- Revenue in SEK (TTM)0.00
- Net income in SEK-16.72m
- Incorporated2012
- Employees--
- LocationAbera Bioscience ABDragarbrunnsgatan 45, Box 1747UPPSALA 751 47SwedenSWE
- Websitehttps://aberabio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alzinova AB | 270.00k | -16.48m | 51.48m | -- | -- | 0.4521 | -- | 190.66 | -0.4149 | -0.4149 | 0.0067 | 2.56 | 0.0023 | -- | 0.3671 | -- | -14.04 | -10.77 | -14.91 | -11.27 | 7,360.55 | -- | -6,103.69 | -18,447.90 | -- | -- | 0.007 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Pila Pharma AB | 1.46m | -9.93m | 54.72m | 1.00 | -- | 8.22 | -- | 37.41 | -0.5304 | -0.5304 | 0.0767 | 0.28 | 0.1513 | -- | 6.11 | 1,463,020.00 | -102.68 | -108.88 | -122.66 | -121.45 | -127.88 | -42.67 | -678.73 | -1,577.64 | -- | -159.47 | 0.104 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
| PCI Biotech Holding ASA | 2.96m | -20.10m | 59.75m | 7.00 | -- | 1.55 | -- | 20.20 | -0.5443 | -0.5443 | 0.0801 | 1.05 | 0.0556 | -- | 0.6848 | -- | -37.78 | -36.44 | -41.97 | -40.14 | -- | -- | -679.43 | -1,055.43 | -- | -- | 0.0081 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
| Orphazyme A/S | 0.00 | -40.80m | 60.29m | 1.00 | -- | 2.70 | -- | -- | -737.75 | -737.75 | 0.00 | 403.34 | 0.00 | -- | -- | 0.00 | -68.42 | -76.08 | -94.18 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
| Scandion Oncology A/S | 0.00 | -61.41m | 61.13m | 4.00 | -- | 1.25 | -- | -- | -1.53 | -1.53 | 0.00 | 1.20 | 0.00 | -- | -- | 0.00 | -63.25 | -45.09 | -76.67 | -52.65 | -- | -- | -- | -- | -- | -- | 0.0158 | -- | -- | -- | 48.89 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -27.98m | 61.44m | -- | -- | 4.72 | -- | -- | -2.67 | -2.67 | 0.00 | 0.6404 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -- | -- | -170.65 | -- | -- | -- | -- | 20.60 | -- | -- | -- |
| Double Bond Phrmcutcl Intrntnl AB (publ) | 1.37m | -17.34m | 63.65m | 10.00 | -- | 11.34 | -- | 46.45 | -0.1837 | -0.1837 | 0.0136 | 0.0556 | 0.1016 | -- | 18.59 | 137,033.00 | -128.49 | -80.90 | -198.98 | -106.45 | -241.22 | -686.41 | -1,265.24 | -1,360.03 | -- | -217.55 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
| Chosa Oncology AB | 73.00k | -23.94m | 64.74m | -- | -- | 3.72 | -- | 886.91 | -0.3524 | -0.3524 | 0.0013 | 0.2684 | 0.003 | -- | 0.013 | -- | -96.68 | -51.96 | -178.66 | -61.92 | -- | -- | -32,798.63 | -708.47 | -- | -97.97 | -- | -- | -98.21 | -- | 28.33 | -- | -- | -- |
| ViroGates A/S | 8.74m | -18.95m | 65.64m | 10.00 | -- | 2.46 | -- | 7.51 | -6.12 | -6.12 | 1.61 | 2.64 | 0.2653 | 0.2654 | 3.15 | 558,300.00 | -57.47 | -46.58 | -63.01 | -52.09 | 78.83 | 77.91 | -216.66 | -238.01 | 8.56 | -23.89 | 0.2376 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
| Abera Bioscience AB | 0.00 | -16.72m | 70.62m | -- | -- | 11.76 | -- | -- | -1.24 | -1.24 | 0.00 | 0.391 | 0.00 | -- | -- | -- | -115.63 | -79.43 | -149.06 | -96.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.73 | -- | -- | -- |
| Combigene AB | 5.54m | -35.67m | 74.65m | 11.00 | -- | 0.641 | -- | 13.47 | -1.80 | -1.80 | 0.28 | 5.88 | 0.0398 | -- | 2.63 | 504,000.00 | -25.58 | -13.00 | -26.56 | -14.58 | -- | -- | -643.33 | -58.77 | -- | -- | -- | -- | -79.24 | 268.58 | -479.27 | -- | -- | -- |
| Spago Nanomedical AB (publ) | 1.20m | -42.22m | 80.90m | 13.00 | -- | 1.91 | -- | 67.25 | -0.3818 | -0.3818 | 0.0115 | 0.1882 | 0.0093 | -- | 5.74 | 92,538.46 | -32.61 | -20.19 | -35.38 | -20.97 | 247.55 | -- | -3,509.81 | -4,853.45 | -- | -- | -- | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Bioextrax AB publ | 2.06m | -21.51m | 85.10m | -- | -- | 3.54 | -- | 41.37 | -0.8026 | -0.8026 | 0.0769 | 0.6968 | 0.0681 | -- | 124.67 | -- | -71.18 | -86.39 | -82.24 | -110.84 | 34.95 | -- | -1,045.55 | -2,119.90 | -- | -- | -- | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| AroCell AB (publ) | 43.04m | -59.30m | 85.69m | -- | -- | 0.5237 | -- | 1.99 | -0.2574 | -0.2574 | 0.1868 | 0.7104 | 0.2095 | 6.68 | 6.52 | -- | -28.86 | -29.25 | -30.70 | -31.37 | -4.38 | -9.85 | -137.78 | -231.19 | 5.25 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| Odi Pharma AB (publ) | 818.38k | -3.97m | 86.75m | -- | -- | 42.61 | -- | 106.01 | -0.2608 | -0.2608 | 0.0538 | 0.1338 | 0.1084 | 1.22 | 6.98 | -- | -52.58 | -- | -95.24 | -- | -53.07 | -- | -484.96 | -- | 1.32 | -14.10 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -27.75m | 89.46m | -- | -- | 0.2577 | -- | -- | -0.0984 | -0.0984 | 0.00 | 0.6946 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -13.84 | -- |
Data as of Apr 18 2024. Currency figures normalised to Abera Bioscience AB's reporting currency: Swedish Krona SEK
0.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| AIFM Capital ABas of 31 Dec 2021 | 130.72k | 0.84% |
Data from 31 Dec 2021 - 31 Dec 2021Source: FactSet Research Systems Inc.
